Clinical Trial Update: Phase 1 Study of CT-996 in Overweight/Obese Participants and Patients With Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

Phase 1 study of CT-996 in overweight/obese participants and individuals with Type 2 diabetes mellitus has completed. The sponsor is Carmot Australia First Pty …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• CT-996

Snippet

Sponsor: Carmot Australia First Pty Ltd | Conditions: Type 2 Diabetes, Overweight or Obesity | Phase 1 | Status: COMPLETED